Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer
Beating Lung Cancer in Ohio (BLCIO) Protocol
Ohio State University Comprehensive Cancer Center
3,584 participants
Jul 17, 2017
INTERVENTIONAL
Conditions
Summary
This randomized clinical trial studies the Beating Lung Cancer in Ohio protocol in improving survival in patients with stage IV non-small cell lung cancer. The Beating Lung Cancer in Ohio protocol may help in evaluating immunotherapies and targeted therapies that prolong survival, have more favorable toxicity profiles than conventional chemotherapy and impact quality of life.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Receive usual care
Undergo collection of tumor tissue and blood sample for repository
Undergo tumor tissue and blood sample for AGIT/DS
Correlative studies
Undergo medical record abstraction
Ancillary studies
Ancillary studies
Undergo usual care or NCCN-driven CTC/DS
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03199651